Dr. Campbell Discusses Advancements in Kidney Cancer Management

Steven Campbell, MD, PhD
Published: Tuesday, Aug 29, 2017



Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses recent advancements in the management of kidney cancer.

The new guidelines for kidney cancer are extremely rich, says Campbell, which is a departure from the basic indexing that has been the standard since 2009.

The functional aspects of the evaluation and management of patients are emphasized in these new guidelines, explains Campbell, including recommendations on staging and who should be referred to the nephrologist.
 
SELECTED
LANGUAGE


Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses recent advancements in the management of kidney cancer.

The new guidelines for kidney cancer are extremely rich, says Campbell, which is a departure from the basic indexing that has been the standard since 2009.

The functional aspects of the evaluation and management of patients are emphasized in these new guidelines, explains Campbell, including recommendations on staging and who should be referred to the nephrologist.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Community Practice Connections™: 2nd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing ApplicationFeb 28, 20192.0
Publication Bottom Border
Border Publication
x